Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

ClinicalTrials.gov ID: NCT00389155

Public ClinicalTrials.gov record NCT00389155. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 7:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized Double-Blind Phase II/III Study in the First-Line Treatment of Advanced Transitional Cell Carcinoma (TCC) of the Urothelium Comparing Vinflunine/Gemcitabine to Placebo/Gemcitabine in Patients Who Are Ineligible to Receive Cisplatin-Based Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test an investigational drug, vinflunine (BMS-710485), in combination with gemcitabine in patients with Transitional Cell Carcinoma who cannot be treated with cisplatin. This study will help to determine whether vinflunine in combination with gemcitabine will extend the time period until further growth of the tumor more than gemcitabine alone.

Study identification

NCT ID
NCT00389155
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
34 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2007 (Type not available)
Primary completion
Jan 2008 (Actual)
Completion
Jan 2008 (Actual)
Last update posted
Dec 7, 2015

2007 – 2008

United States locations

U.S. sites
64
U.S. states
29
U.S. cities
56
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294 —
Acrc/Arizona Clinical Research Center, Inc. Tucson Arizona 85715 —
Tower Hematology Oncology Medical Group Beverly Hills California 90211 —
Local Institution Concord California 94520 —
Glendale Memorial Hospital And Health Center Glendale California 91204 —
Moores Ucsd Cancer Center La Jolla California 92093 —
North Valley Hematology/Oncology Medical Group Mission Hills California 91345 —
Local Institution Orange California 92868 —
Stanford University Stanford California 94305 —
Local Institution Newark Delaware 19718 —
University Of Florida College Of Medicine At Jacksonville Jacksonville Florida 32209 —
Local Institution Jacksonville Florida 32224 —
Lakeland Regional Cancer Center Lakeland Florida 33805 —
University Of Miami Miami Florida 33136 —
Advanced Medical Specialties Miami Florida 33176 —
Medical College Of Georgia Augusta Georgia 30912 —
Central Georgia Cancer Care, Pc Macon Georgia 31201 —
University Of Chicago Chicago Illinois 60637 —
Springfield Clinic, Llp Springfield Illinois 62703 —
Michiana Hematology Oncology, P.C. South Bend Indiana 46601 —
James Graham Brown Cancer Center Louisville Kentucky 40202 —
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore Maryland 21231 —
Henry Ford Hospital Detroit Michigan 48202 —
Mitchell Folbe, Md, Pc Troy Michigan 48085 —
Local Institution Minneapolis Minnesota 55455 —
Local Institution Rochester Minnesota 55905 —
Missouri Cancer Associates Columbia Missouri 65201 —
University Of Missouri Healthcare/Ellis Fischel Cancer Ctr Columbia Missouri 65203 —
Capital Comprehensive Cancer Care Center Jefferson City Missouri 65109 —
Kansas City Veterans Affairs Medical Center Kansas City Missouri 64128 —
Washington University School Of Medicine St Louis Missouri 63110 —
Billings Clinic Billings Montana 59101 —
Hematology Oncology Centers Of The Northern Rockies, Pc Billings Montana 59101 —
Nevada Cancer Institute Las Vegas Nevada 89135 —
Nevada Cancer Centers Las Vegas Nevada 89169 —
The Cancer Center At Hackensack University Medical Center Hackensack New Jersey 07601 —
The Mary Imogene Bassett Hospital Cooperstown New York 13326 —
Columbia University Medical Center New York New York 10032 —
New York Presbyterian Hospital New York New York 10065 —
University Of Rochester Rochester New York 14642 —
Albert Einstein Cancer Center The Bronx New York 10461 —
Carolinas Hematology Oncology Associates Charlotte North Carolina 28203 —
Mid Dakota Clinic, Pc Bismarck North Dakota 58501 —
Cleveland Clinic Cleveland Ohio 44195 —
Mid-Ohio Oncology/Hematology, Inc. Dba Columbus Ohio 43219 —
Abramson Cancer Center Of The Philadelphia Pennsylvania 19104 —
Guthrie Foundation For Education And Research Sayre Pennsylvania 18840 —
Charleston Cancer Center Charleston South Carolina 29406 —
Medical University Of South Carolina Charleston South Carolina 29425 —
The Jones Clinic, Pc Germantown Tennessee 38138 —
The West Clinic Memphis Tennessee 38120 —
The Sarah Cannon Research Institute Nashville Tennessee 37203 —
Lone Star Oncology Consulants, Pa Austin Texas 78759 —
Cancer Specialists Of South Texas, Pa Corpus Christi Texas 78412 —
The Center For Cancer And Blood Disorders Fort Worth Texas 76104 —
University Of Texas Medical Branch Of Galveston Galveston Texas 77555 —
South Texas Oncology And Hematology, P.A. San Antonio Texas 78207 —
Northern Utah Associates Ogden Utah 84403 —
Cancer Outreach Associates, Pc Abingdon Virginia 24211 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Mason Medical Center Seattle Washington 98101 —
Univ. Of Washington Medical Ctr., Prostate-Oncology Ctr Seattle Washington 98195 —
West Virginia University Morgantown West Virginia 26506 —
Local Institution Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00389155, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2015 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00389155 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →